Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease
RBCs become hard, deoxygenated and crescent- or C-shaped in patients with haemoglobin polymerisation. Credit: Global Blood Therapeutics, Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more